Squarepoint Ops LLC Crispr Therapeutics Ag Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Squarepoint Ops LLC holds 248,979 shares of CRSP stock, worth $11.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

248,979

Previous 11,800 2009.99%

Holding current value

$11.5 Million

Previous $637,000 1736.58%

% of portfolio

0.02%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$44.62 - $62.75 $885,439 - $1.25 Million	-19,844 Reduced 7.38%	248,979 $11.7 Million
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $266,442 - $355,013	-5,207 Reduced 1.9%	268,823 $14.5 Million
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $8.9 Million - $13.1 Million	146,672 Added 115.17%	274,030 $18.7 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $2,085 - $3,897	-54 Reduced 0.04%	127,358 $7.97 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $152,405 - $237,601	-3,506 Reduced 2.68%	127,412 $7.15 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $1.46 Million - $1.99 Million	-35,516 Reduced 21.34%	130,918 $5.92 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $3.79 Million - $6.36 Million	96,783 Added 138.95%	166,434 $6.77 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $4.26 Million - $5.84 Million	69,651 New	69,651 $4.55 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $595,080 - $845,855	-5,400 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $650,619 - $1.04 Million	-6,452 Reduced 54.44%	5,400 $874,000
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $752,563 - $1.43 Million	6,797 Added 134.46%	11,852 $1.44 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $402,731 - $875,677	5,055 New	5,055 $774,000
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $521,020 - $1.03 Million	-13,533 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $1.46 Million - $2.71 Million	-43,352 Reduced 76.21%	13,533 $574,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $2.09 Million - $4.16 Million	56,885 New	56,885 $3.47 Million
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $260,204 - $333,650	-6,348 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $17,512 - $23,810	494 Added 8.44%	6,348 $299,000
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $406,177 - $592,451	-14,496 Reduced 71.23%	5,854 $209,000
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $462,555 - $861,619	20,350 New	20,350 $581,000
Q2 2018 Aug 14, 2018	SELL	$42.62 - $73.59 $337,507 - $582,759	-7,919 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $186,254 - $460,648	7,919 New	7,919 $362,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Crispr Therapeutics Ag Transaction History